Efek Samping Terapi Antiretroviral dan Kepatuhan Berobat Penderita HIV/AIDS

Authors

  • Rico Januar Sitorus Fakultas Kesehatan Masyarakat, Universitas Sriwijaya http://orcid.org/0000-0002-4933-4429
  • Novrikasari Novrikasari Fakultas Kesehatan Masyarakat, Universitas Sriwijaya
  • Rizma Adliah Syakurah Fakultas Kesehatan Masyarakat, Universitas Sriwijaya
  • Merry Natalia Kantor Kesehatan Pelabuhan (KKP), Palembang

DOI:

https://doi.org/10.26630/jk.v12i3.2869

Keywords:

Adherence, Antiretrovirals, HIV/AIDS, Side-effects.

Abstract

Antiretroviral treatment side-effects and patient compliance with medical instructions continue to be a growing challenge for HIV/AIDS patients. Arv therapy has resulted in a substantial intervention that has been successful in preventing transmission and opportunistic infection. The main objective of this study was to analyze the association between side-effects of ARV therapy and medication adherence as well as another potential confounding such as opportunistic infection, family support, stress level, knowledge of ARV, marital status, and occupation. This study is a quantitative approach by using cross-sectional methods. A total of 244 respondents from 1.180 patients with confirmed HIV registered in the Care Support and Treatment (CST) service and Sriwijaya Community in the City of Palembang to respond to the survey. Non-random sampling was used to collect the samples. As the result, the majority of the respondents were male (84,43 %), ≥30 years old (57,4%), and secondary school graduates (52%). After adjusting with stress and opportunistic infection variable, a Multivariate regression analysis revealed a positive relationship between side effects and medication adherence (p-value of 0,041; 0,05), OR Adj 2,131 (1,190-4,988). PLHV who had adverse effects had a 2.131 times worse adherence rate than those who did not. In conclusion, medication adherence must be greatly improved in light of therapeutic side effects, stress levels, and opportunistic infection.

Author Biography

Rico Januar Sitorus, Fakultas Kesehatan Masyarakat, Universitas Sriwijaya

I am a lecturer at Publich Health Faculty, Universitas Sriwijaya

References

Centers for Disease Control and Prevention. (2021). HIV Treatment. https://www.cdc.gov/hiv/basics/livingwithhiv/treatment.html. (n.d.).

Dima, A. L., Schweitzer, A.-M., Diaconiţǎ, R., Remor, E., & Wanless, R. S. (2013). Adherence to ARV medication in Romanian young adults: Self-reported behaviour and psychological barriers. Psychology, Health & Medicine, 18(3), 343-354. https://doi.org/10.1080/13548506.2012.722648

Gaolathe, T., Wirth, K. E., Holme, M. P., Makhema, J., Moyo, S., Chakalisa, U., Yankinda, E. K., Lei, Q., Mmalane, M., & Novitsky, V. (2016). Botswana’s progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. The Lancet HIV, 3(5), e221-e230.

Frank, T. D., Carter, A., Jahagirdar, D., Biehl, M. H., Douwes-Schultz, D., Larson, S. L., ... & Hosseinzadeh, M. (2019). Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. The lancet HIV, 6(12), e831-e859.

Geng, E. H., Odeny, T. A., Lyamuya, R., Nakiwogga-Muwanga, A., Diero, L., Bwana, M., Braitstein, P., Somi, G., Kambugu, A., & Bukusi, E. (2016). Retention in care and patient-reported reasons for undocumented transfer or stopping care among HIV-infected patients on antiretroviral therapy in Eastern Africa: application of a sampling-based approach. Clinical Infectious Diseases, 62(7), 935-944.

Ionita, G., Malviya, A., Rajbhandari, R., Schluter, W. W., Sharma, G., Kakchapati, S., Rijal, S., & Dixit, S. (2017). Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study. International Journal of Infectious Diseases, 60, 64-69. https://doi.org/https://doi.org/10.1016/j.ijid.2017.04.011

Montaner, J. S. G., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., Wood, E., Kerr, T., Shannon, K., & Moore, D. (2014). Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as Prevention†experience in a Canadian setting. PloS One, 9(2), e87872.

Nabukeera-Barungi, N., Elyanu, P., Asire, B., Katureebe, C., Lukabwe, I., Namusoke, E., Musinguzi, J., Atuyambe, L., & Tumwesigye, N. (2015). Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda. BMC Infectious Diseases, 15(1), 1-10.

Najjar, A., Amro, Y., Kitaneh, I., Abu-Sharar, S., Sawalha, M., Jamous, A., Qiq, M., Makharzeh, E., Subb Laban, B., Amro, W., & Amro, A. (2015). Knowledge and Adherence to Medications among Palestinian Geriatrics Living with Chronic Diseases in the West Bank and East Jerusalem. PloS One, 10(6), e0129240-e0129240. https://doi.org/10.1371/journal.pone.0129240

Ndiaye, M., Nyasulu, P., Nguyen, H., Lowenthal, E. D., Gross, R., Mills, E. J., & Nachega, J. B. (2013). Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study. Patient Preference and Adherence, 7, 891.

Oguntibeju, O. O. (2012). Quality of life of people living with HIV and AIDS and antiretroviral therapy. Hiv/Aids (Auckland, NZ), 4, 117.

Olem, D., Sharp, K. M., Taylor, J. M., & Johnson, M. O. (2014). Overcoming barriers to HIV treatment adherence: A brief cognitive behavioral intervention for HIV-positive adults on antiretroviral treatment. Cognitive and Behavioral Practice, 21(2), 206-223.

Olowookere, S. A., Fatiregun, A. A., Ladipo, M. M. A., Abioye-Kuteyi, E. A., & Adewole, I. F. (2016). Effects of adherence to antiretroviral therapy on body mass index, immunological and virological status of Nigerians living with HIV/AIDS. Alexandria Journal of Medicine, 52(1), 51-54. https://doi.org/https://doi.org/10.1016/j.ajme.2015.03.001.

Pellowski, J. A., & Kalichman, S. C. (2016). Health behavior predictors of medication adherence among low health literacy people living with HIV/AIDS. Journal of Health Psychology, 21(9), 1981-1991. https://doi.org/10.1177/1359105315569617

Peltzer, K., & Pengpid, S. (2013). Socioeconomic factors in adherence to HIV therapy in low-and middle-income countries. Journal of Health, Population, and Nutrition, 31(2), 150.

Petty, L. A., Steinbeck, J. L., Pursell, K., & Jensen, D. M. (2014). Human immunodeficiency virus and coinfection with hepatitis B and C. Infectious Disease Clinics, 28(3), 477-499.

Tadesse, W. T., Mekonnen, A. B., Tesfaye, W. H., & Tadesse, Y. T. (2014). Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study. BMC Pharmacology and Toxicology, 15(1), 1-9.

Themanson, J. R., & Rosen, P. J. (2015). Examining the relationships between self-efficacy, task-relevant attentional control, and task performance: Evidence from event-related brain potentials. British Journal of Psychology, 106(2), 253-271. https://doi.org/https://doi.org/10.1111/bjop.12091

UNAIDS. (2020). HIV Prevention 2020 Road Map. http://www.unaids.org/sites/default/files/media_asset/hiv-prevention-2020-road-map_en.pdf

WHO. (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. World Health Organization.

WHO. (2015). Fact sheet to the WHO consolidated guidelines on HIV testing services. World Health Organization.

WHO. (2021). HIV-AIDS. https://www.who.int/news-room/fact-sheets/detail/hiv-aids. (n.d.). Geneva.

Zhang, L., Li, X., Lin, Z., Jacques-Tiura, A. J., Xu, J., Zhou, Y., Qiao, S., Shen, Z., & Stanton, B. (2016). Side effects, adherence self-efficacy, and adherence to antiretroviral treatment: a mediation analysis in a Chinese sample. AIDS Care, 28(7), 919-926. https://doi.org/10.1080/09540121.2015.1124984.

Downloads

Additional Files

Published

30-11-2021

Issue

Vol. 12 No. 3 (2021): Jurnal Kesehatan

Section

Articles

License

Authors who publish in this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.